3308 articles
Eduardo Dunayevich, MD, Vice President, VMAT2 Franchise Leader, and Clinical Business Development Leader for Neurocrine Biosciences, Inc.
Joe Todisco, CEO of CorMedix, a biopharmaceutical company focused on developing and commercializing therapeutic products that prevent infection and othe...
Allen Comer, Senior Director, Research at Stratatech Corporation, a Mallinckrodt company, discusses a recent advancement in burn care and why there shou...
Waqaas Al-Siddiq, founder and CEO of Biotricity, Inc., a med tech company, discusses the role of AI in the future of wearable heart monitoring devices...
Hema Tallman, SVP and Global Head of BioLife Plasma Services at Takeda, an industry leader in the collection of high-quality plasma and a supporting dri...
David Bearss, PhD, President and CEO at Halia Therapeutics, a clinical-stage biopharma company developing novel therapies to improve the lives of patien...
Schizophrenia is a serious and complex mental illness that left untreated can disrupt a person's relationships, physical health, and plans for the futur...
Mark McDonough, CEO of ChromaCode, a molecular diagnostics company, discusses how ChromaCode technology provides a cost-effective, rapid, and accurate...
Amelia Korangy, Director of External Affairs Strategy and Programs at ViiV Healthcare - the only pharmaceutical company solely focused on HIV, discusses...
Amy Meyer, Manager of Primate Experimentation Campaigns for People for the Ethical Treatment of Animals (PETA) discusses what is happening to animals in...